SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004059
Filing Date
2019-05-06
Accepted
2019-05-06 14:57:15
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adap-20190331x10q.htm 10-Q 1830757
2 EX-31.1 adap-20190331ex311d5adfc.htm EX-31.1 11039
3 EX-31.2 adap-20190331ex312da56f1.htm EX-31.2 11837
4 EX-32.1 adap-20190331ex321e2c52a.htm EX-32.1 6822
5 EX-32.2 adap-20190331ex32298c362.htm EX-32.2 6837
6 GRAPHIC adap20190331x10q001.jpg GRAPHIC 84034
  Complete submission text file 0001558370-19-004059.txt   5186164

Data Files

Seq Description Document Type Size
7 EX-101.INS adap-20190331.xml EX-101.INS 934719
8 EX-101.SCH adap-20190331.xsd EX-101.SCH 34301
9 EX-101.CAL adap-20190331_cal.xml EX-101.CAL 56124
10 EX-101.DEF adap-20190331_def.xml EX-101.DEF 55420
11 EX-101.LAB adap-20190331_lab.xml EX-101.LAB 299120
12 EX-101.PRE adap-20190331_pre.xml EX-101.PRE 202675
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 19799029
SIC: 2836 Biological Products, (No Diagnostic Substances)